Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

WINDLAS BIOTECH LTD.

NSE : WINDLASBSE : 543329ISIN CODE : INE0H5O01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE823.9537.45 (+4.76 %)
PREV CLOSE () 786.50
OPEN PRICE () 789.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3823
TODAY'S LOW / HIGH ()770.00 885.00
52 WK LOW / HIGH ()667.3 1137.6
NSE823.4035.35 (+4.49 %)
PREV CLOSE() 788.05
OPEN PRICE () 785.10
BID PRICE (QTY) 823.40 (331)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 43341
TODAY'S LOW / HIGH() 766.20 878.70
52 WK LOW / HIGH ()665.1 1140
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2001

Management Info :

Vivek Dhariwal - Chairman Hitesh Windlass - Managing Director

Registered Office :

Address : 40 / 1,Mohabewala Industrial Area,,
Dehradun,
Uttarakhand-248110

Phone : 0135-6608000-30

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
29Jan Windlas Biotech informs about conferen
Pursuant to Clause 15 of Schedule III, Part A, Para A read with Regulati..
29Oct Windlas Biotech informs about analyst
Windlas Biotech has informed that the conference call to discuss financi..
12Aug Windlas Biotech informs about results
Windlas Biotech has informed that it enclosed the Results Presentation f..
12Aug Windlas Biotech informs about outcome
In terms of Regulation 30 and 33 of the Securities & Exchange Board..
30Jun Windlas Biotech informs about analyst
Windlas Biotech has informed that the officials of the Company will be m..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit178606.49
Gross Profit 235.88 793.94
Operating Profit 322.011117.61
Net Sales 2223.987598.78
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Gland Pharma (BSE)
 1799.40 (6.56%)
M.Cap ( in Cr)
29646.27
NGL Fine-Chem (BSE)
 1785.00 (4.58%)
M.Cap ( in Cr)
1102.78
Acutaas Chemicals (BSE)
 1936.00 (3.84%)
M.Cap ( in Cr)
15850.25
Ipca Laboratories (BSE)
 1482.10 (2.36%)
M.Cap ( in Cr)
37601.50
Venus Remedies (BSE)
 784.65 (3.24%)
M.Cap ( in Cr)
1048.84
Shareholding Pattern
PROMOTERS 61.99%
NON-INSTITUTION 25.64%
MUTUAL FUNDS/UTI 6.63%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX82566.37221.69 (0.27%)
NIFTY25418.9076.15 (0.30%)
Dow Jones 49015.6012.19 (0.02%)
Nasdaq 23857.4540.35 (0.17%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI